meningococcal ABCWY pentavalent vaccine (Pending FDA Approval)

Brand and Other Names:
Sections

Dosing & Uses

AdultPediatric

Meningococcal Vaccination

Pending FDA approval for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, B, C, Y, and W-135 in persons aged 10-25 years

Meningococcal Vaccination

Pending FDA approval for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, B, C, Y, and W-135 in persons aged 10-25 years

Next:

Pharmacology

Mechanism of Action

Pentavalent vaccine targeting meningococcal serogroups A, B, C, Y and W

Conveys active immunity via stimulation of production of endogenously produced antibodies

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.